Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides.
Athikkavil FM, Aiswarya SU, Johny R, Sudhesh M, Nisthul AA, Lankalapalli RS, Anto RJ, Bava SV. Athikkavil FM, et al. Among authors: aiswarya su. Explor Target Antitumor Ther. 2023;4(2):227-239. doi: 10.37349/etat.2023.00131. Epub 2023 Apr 24. Explor Target Antitumor Ther. 2023. PMID: 37205312 Free PMC article.
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma.
Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N, Anto RJ. Nath LR, et al. Among authors: aiswarya su. Front Oncol. 2022 Feb 8;12:812598. doi: 10.3389/fonc.2022.812598. eCollection 2022. Front Oncol. 2022. PMID: 35211405 Free PMC article.
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma.
Swetha M, Keerthana CK, Rayginia TP, Nath LR, Haritha NH, Shabna A, Kalimuthu K, Thangarasu AK, Aiswarya SU, Jannet S, Pillai S, Harikumar KB, Sundaram S, Anto NP, Wu DH, Lankalapalli RS, Towner R, Isakov N, Deepa SS, Anto RJ. Swetha M, et al. Among authors: aiswarya su. Pharmaceuticals (Basel). 2022 May 22;15(5):636. doi: 10.3390/ph15050636. Pharmaceuticals (Basel). 2022. PMID: 35631464 Free PMC article.
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma.
Nath LR, Swetha M, Vijayakurup V, Thangarasu AK, Haritha NH, Shabna A, Aiswarya SU, Rayginia TP, Keerthana CK, Kalimuthu K, Sundaram S, Lankalapalli RS, Pillai S, Towner R, Isakov N, Anto RJ. Nath LR, et al. Among authors: aiswarya su. Front Oncol. 2022 Aug 25;12:991401. doi: 10.3389/fonc.2022.991401. eCollection 2022. Front Oncol. 2022. PMID: 36091117 Free PMC article.
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
Shabna A, Antony J, Vijayakurup V, Saikia M, Liju VB, Retnakumari AP, Amrutha NA, Alex VV, Swetha M, Aiswarya SU, Jannet S, Unni US, Sundaram S, Sherin DR, Anto NP, Bava SV, Chittalakkottu S, Ran S, Anto RJ. Shabna A, et al. Among authors: aiswarya su. Cell Mol Life Sci. 2022 Aug 10;79(9):478. doi: 10.1007/s00018-022-04476-y. Cell Mol Life Sci. 2022. PMID: 35948813
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: aiswarya su. Front Oncol. 2023 Dec 15;13:1302413. doi: 10.3389/fonc.2023.1302413. eCollection 2023. Front Oncol. 2023. PMID: 38162481 Free PMC article.
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: aiswarya su. Front Oncol. 2021 Jul 15;11:656804. doi: 10.3389/fonc.2021.656804. eCollection 2021. Front Oncol. 2021. PMID: 34336653 Free PMC article.